Alpha Diagnostic International, Inc. Anti-human TIE-2 antiserum #2 TIE22-S

Anti-human TIE-2 antiserum #2 General Information Embryonic vascular system undergoes a series of complex, highly regulated series of events involving differentiation, migration and association of primitive endothelial cells. This process is termed vasculogenesis. A further remodeling of the primitive SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 18-aa peptide of Human TIE2 ; Designated (TIE22-P or control peptide) conjugated to KLH; epitope location ~ N-terminus, Extracellular domain SpCrossreactivity Human TIE22-P sequence is 100% conserved in rat, mice, and 94% bovine Tie-2. The peptide is specific for Tie-2 as no significant sequence homology is seem with Tie-1. Antibody crossreactivity in various species is not established For research use only, not for diagnostic or therapeutic use.